marketcaparena
Search

    SGHT

    Sight Sciences, Inc.

    Company overview

    Market capitalization
    $510.67M
    Employees
    186
    Latest publication
    2026-09-29
    About Sight Sciences, Inc.

    Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye. It offers OMNI, a surgical system family of products, such as OMNI Ergo for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and OMNI EDGE, an implant-free and minimally invasive glaucoma surgery technology. The company also provides SION, a bladeless and manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork; and TearCare system, a proprietary, interventional, dry eye device designed to melt and facilitate the comprehensive removal of meibomian gland obstructions and restore gland functionality and healthy oil production for adult patients with evaporative dry eye disease due to meibomian gland disease when used in conjunction with manual expression of the meibomian glands for ophthalmologists and optometrists. It serves hospitals, medical centers, and eyecare professionals through sales representatives and distributors. The company was incorporated in 2010 and is headquartered in Menlo Park, California.

    Company website

    Financial statements

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Assets109,702,000USD115,300,000USD116,256,000USD121,971,000USD129,680,000USD142,839,000USD143,597,000USD149,715,000USD
    Other Current Assets3,948,000USD3,257,000USD3,494,000USD2,103,000USD2,909,000USD2,306,000USD2,885,000USD1,452,000USD
    Total Liab55,799,000USD51,358,000USD51,966,000USD51,959,000USD52,052,000USD55,316,000USD48,640,000USD48,077,000USD
    Total Stockholder Equity53,903,000USD63,942,000USD64,290,000USD70,012,000USD77,628,000USD87,523,000USD94,957,000USD101,638,000USD
    Other Current Liab12,522,000USD9,209,000USD9,520,000USD9,294,000USD8,805,000USD13,244,000USD11,983,000USD10,857,000USD
    Common Stock54,000USD54,000USD52,000USD52,000USD51,000USD51,000USD50,000USD50,000USD
    Capital Stock54,000USD54,000USD52,000USD52,000USD51,000USD51,000USD50,000USD50,000USD
    Retained Earnings-397,703,000USD-384,723,000USD-380,561,000USD-372,392,000USD-360,451,000USD-346,297,000USD-334,451,000USD-323,385,000USD
    Cash84,962,000USD91,965,000USD92,373,000USD101,500,000USD108,768,000USD120,357,000USD118,564,000USD118,177,000USD
    Cash And Short Term Investments84,962,000USD91,965,000USD92,373,000USD101,500,000USD108,768,000USD120,357,000USD118,564,000USD118,177,000USD
    Total Current Assets106,512,000USD112,734,000USD113,595,000USD119,431,000USD126,906,000USD139,774,000USD140,469,000USD146,329,000USD
    Total Current Liabilities18,163,000USD11,027,000USD11,831,000USD11,936,000USD12,122,000USD15,468,000USD13,799,000USD13,288,000USD
    Net Debt-43,201,000USD-51,190,000USD-51,688,000USD-60,930,000USD-68,305,000USD-79,995,000USD-83,279,000USD-83,152,000USD
    Short Term Debt4,155,000USD475,000USD569,000USD566,000USD552,000USD533,000USD519,000USD508,000USD
    Short Long Term Debt3,797,000USD———————
    Short Long Term Debt Total41,761,000USD40,775,000USD40,685,000USD40,570,000USD40,463,000USD40,362,000USD35,285,000USD35,025,000USD
    Long Term Debt36,736,000USD40,300,000USD40,069,000USD39,821,000USD39,583,000USD39,356,000USD34,152,000USD33,770,000USD
    Net Receivables10,595,000USD9,745,000USD9,744,000USD9,614,000USD9,424,000USD10,786,000USD12,929,000USD19,919,000USD
    Inventory7,007,000USD7,767,000USD7,984,000USD6,214,000USD5,805,000USD6,325,000USD6,091,000USD6,781,000USD
    Accounts Payable1,486,000USD1,343,000USD1,742,000USD2,076,000USD2,765,000USD1,691,000USD1,297,000USD1,923,000USD
    Property Plant Equipment Net2,820,000USD2,048,000USD2,113,000USD2,154,000USD2,302,000USD2,515,000USD2,548,000USD2,746,000USD
    Property Plant Equipment Gross5,268,000USD4,449,000USD4,452,000USD4,435,000USD4,502,000USD4,621,000USD4,523,000USD4,659,000USD
    Common Stock Shares Outstanding53,943,085shares53,082,214shares52,377,805shares51,821,773shares51,290,665shares50,797,080shares50,340,603shares49,903,386shares
    Non Current Assets Total3,190,000USD2,566,000USD2,661,000USD2,540,000USD2,774,000USD3,065,000USD3,128,000USD3,386,000USD
    Non Current Liabilities Total37,636,000USD40,331,000USD40,135,000USD40,023,000USD39,930,000USD39,848,000USD34,841,000USD34,789,000USD
    Non Current Liabilities Other30,000USD31,000USD19,000USD19,000USD19,000USD19,000USD75,000USD76,000USD
    Non Currrent Assets Other370,000USD518,000USD548,000USD386,000USD472,000USD550,000USD580,000USD640,000USD
    Net Working Capital88,349,000USD101,707,000USD101,764,000USD107,495,000USD114,784,000USD124,306,000USD126,670,000USD133,041,000USD
    Unclassified Current Liabilities-3,797,000USD———————
    Unclassified Equity451,498,000USD448,557,000USD444,747,000USD442,300,000USD437,977,000USD433,718,000USD429,308,000USD424,923,000USD
    Other Assets———————1USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets115,300,000USD142,839,000USD166,651,000USD213,073,000USD280,186,000USD72,806,000USD30,741,000USD8,094,000USD
    Other Current Assets3,257,000USD2,306,000USD2,604,000USD3,415,000USD4,164,000USD1,161,000USD426,000USD621,000USD
    Total Liab51,358,000USD55,316,000USD46,436,000USD52,997,000USD48,079,000USD161,655,000USD85,424,000USD37,056,000USD
    Total Stockholder Equity63,942,000USD87,523,000USD120,215,000USD160,076,000USD232,107,000USD-88,849,000USD-54,683,000USD-28,962,000USD
    Other Current Liab9,209,000USD13,244,000USD7,729,000USD14,096,000USD9,643,000USD6,761,000USD4,464,000USD1,017,000USD
    Common Stock54,000USD51,000USD49,000USD48,000USD48,000USD9,000USD9,000USD9,000USD
    Capital Stock54,000USD51,000USD49,000USD48,000USD48,000USD9,000USD9,000USD9,000USD
    Retained Earnings-384,723,000USD-346,297,000USD-294,790,000USD-239,243,000USD-153,001,000USD-90,041,000USD-55,348,000USD-29,479,000USD
    Cash91,965,000USD120,357,000USD138,129,000USD185,000,000USD260,687,000USD61,511,000USD21,237,000USD4,242,000USD
    Cash And Short Term Investments91,965,000USD120,357,000USD138,129,000USD185,000,000USD260,687,000USD61,511,000USD21,237,000USD4,242,000USD
    Total Current Assets112,734,000USD139,774,000USD162,871,000USD209,677,000USD277,035,000USD70,633,000USD28,001,000USD7,164,000USD
    Total Current Liabilities11,027,000USD15,468,000USD12,252,000USD17,817,000USD13,504,000USD9,314,000USD7,336,000USD2,896,000USD
    Net Debt-51,190,000USD-79,995,000USD-102,715,000USD-150,019,000USD-228,031,000USD-29,027,000USD-7,297,000USD29,911,000USD
    Short Term Debt475,000USD533,000USD2,792,000USD1,033,000USD510,000USD395,000USD557,000USD—
    Short Long Term Debt Total40,775,000USD40,362,000USD35,414,000USD34,981,000USD33,166,000USD32,484,000USD13,940,000USD34,153,000USD
    Long Term Debt40,300,000USD39,356,000USD31,708,000USD33,313,000USD32,656,000USD31,955,000USD12,855,000USD—
    Net Receivables9,745,000USD10,786,000USD14,289,000USD15,148,000USD8,709,000USD5,363,000USD4,094,000USD1,815,000USD
    Inventory7,767,000USD6,325,000USD7,849,000USD6,114,000USD3,475,000USD2,598,000USD2,244,000USD486,000USD
    Accounts Payable1,343,000USD1,691,000USD1,731,000USD2,688,000USD3,351,000USD2,158,000USD2,315,000USD1,879,000USD
    Property Plant Equipment Net2,048,000USD2,515,000USD3,098,000USD3,185,000USD2,949,000USD1,787,000USD2,572,000USD868,000USD
    Property Plant Equipment Gross4,449,000USD4,621,000USD4,725,000USD3,185,000USD2,949,000USD1,787,000USD2,572,000USD868,000USD
    Common Stock Shares Outstanding52,148,543shares50,134,104shares48,628,940shares47,849,058shares47,504,704shares46,766,346shares33,627,170shares32,202,665shares
    Non Current Assets Total2,566,000USD3,065,000USD3,780,000USD3,396,000USD3,151,000USD2,173,000USD2,740,000USD930,000USD
    Non Current Liabilities Total40,331,000USD39,848,000USD34,184,000USD35,180,000USD34,575,000USD152,341,000USD78,088,000USD34,160,000USD
    Non Current Liabilities Other31,000USD19,000USD38,000USD1,867,000USD1,919,000USD344,000USD—7,000USD
    Non Currrent Assets Other518,000USD550,000USD682,000USD211,000USD202,000USD386,000USD168,000USD62,000USD
    Net Working Capital101,707,000USD124,306,000USD150,619,000USD191,860,000USD263,531,000USD61,319,000USD20,665,000USD4,268,000USD
    Unclassified Equity448,557,000USD433,718,000USD414,907,000USD399,223,000USD665,198,000USD120,617,000USD65,139,000USD34,652,000USD
    Short Long Term Debt——2,219,000USD—————
    Unclassified Current Liabilities——-2,219,000USD—————
    Unclassified Non Current Liabilities——2,438,000USD-1,232,000USD-1,919,000USD118,833,000USD65,020,000USD34,146,000USD
    Other Liab———1,232,000USD1,919,000USD809,000USD213,000USD7,000USD
    Other Assets———211,000USD202,000USD386,000USD168,000USD62,000USD
    Accumulated Other Comprehensive Income———0USD-280,186,000USD-119,443,000USD-64,492,000USD-34,153,000USD
    Net Tangible Assets———160,076,000USD232,107,000USD-88,849,000USD-54,683,000USD-28,962,000USD
    Deferred Long Term Liab—————400,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-12,980,000USD-4,162,000USD-8,169,000USD-11,941,000USD-14,154,000USD-11,846,000USD-11,066,000USD-12,329,000USD
    Depreciation103,000USD108,000USD105,000USD125,000USD149,000USD176,000USD244,000USD100,000USD
    Stock Based Compensation2,853,000USD2,549,000USD2,420,000USD3,842,000USD4,243,000USD3,946,000USD4,308,000USD4,317,000USD
    Other Non Cash Items194,000USD475,000USD368,000USD382,000USD361,000USD453,000USD5,715,000USD4,409,000USD
    Change To Account Receivables-722,000USD-102,000USD-98,000USD-215,000USD1,327,000USD2,118,000USD7,161,000USD-4,344,000USD
    Change To Inventory788,000USD214,000USD-1,791,000USD-406,000USD541,000USD-233,000USD704,000USD156,000USD
    Change In Working Capital2,801,000USD-797,000USD-3,443,000USD49,000USD-2,204,000USD3,812,000USD1,399,000USD-1,886,000USD
    Total Cash From Operating Activities-7,029,000USD-1,827,000USD-8,719,000USD-7,543,000USD-11,605,000USD-3,459,000USD600,000USD-9,706,000USD
    Capital Expenditures-60,000USD-156,000USD-170,000USD-210,000USD0USD-137,000USD-51,000USD-80,000USD
    Free Cash Flow-7,089,000USD-1,671,000USD-8,889,000USD-7,753,000USD-11,605,000USD-3,596,000USD549,000USD-9,786,000USD
    Total Cashflows From Investing Activities-60,000USD156,000USD-170,000USD-210,000USD—-137,000USD-51,000USD-80,000USD
    Total Cash From Financing Activities88,000USD1,265,000USD25,000USD485,000USD16,000USD5,389,000USD-162,000USD679,000USD
    Change In Cash-7,003,000USD-406,000USD-8,864,000USD-7,268,000USD-11,589,000USD1,793,000USD387,000USD-9,107,000USD
    Begin Period Cash Flow91,965,000USD92,636,000USD101,500,000USD108,768,000USD120,357,000USD118,564,000USD118,177,000USD127,284,000USD
    End Period Cash Flow84,962,000USD92,230,000USD92,636,000USD101,500,000USD108,768,000USD120,357,000USD118,564,000USD118,177,000USD
    Other Cashflows From Financing Activities-11,000USD-3,000USD-1,000USD-7,000USD-47,000USD-3,000USD-238,000USD-20,000USD
    Net Borrowings—0USD0USD0USD0USD5,000,000USD0USD—
    Unclassified Financing Cash Flow—1,268,000USD——————
    Investments——-170,000USD-210,000USD0USD-137,000USD-51,000USD-80,000USD
    Sale Purchase Of Stock——-1,000USD———20,000USD-20,000USD
    Unclassified Operating Cash Flow———————-4,317,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-38,426,000USD-51,507,000USD-55,547,000USD-86,242,000USD-62,960,000USD-34,693,000USD-25,869,000USD-14,290,000USD
    Depreciation487,000USD712,000USD614,000USD710,000USD632,000USD554,000USD295,000USD63,000USD
    Stock Based Compensation13,054,000USD17,077,000USD14,581,000USD12,963,000USD5,083,000USD497,000USD118,000USD52,000USD
    Other Non Cash Items1,586,000USD2,367,000USD2,302,000USD2,300,000USD1,270,000USD684,000USD800,000USD58,000USD
    Change To Account Receivables912,000USD3,545,000USD661,000USD-6,841,000USD-3,694,000USD-1,477,000USD-2,320,000USD-1,415,000USD
    Change To Inventory-1,442,000USD1,630,000USD-2,156,000USD-3,253,000USD-1,313,000USD-1,716,000USD-1,799,000USD-184,000USD
    Change In Working Capital-6,395,000USD9,000,000USD-9,134,000USD-5,696,000USD-4,325,000USD784,000USD-341,000USD-358,000USD
    Total Cash From Operating Activities-29,694,000USD-22,351,000USD-47,184,000USD-75,965,000USD-52,540,000USD-32,174,000USD-24,997,000USD-14,475,000USD
    Capital Expenditures-224,000USD-385,000USD-791,000USD-970,000USD-813,000USD-953,000USD-672,000USD-570,000USD
    Free Cash Flow-29,918,000USD-22,736,000USD-47,975,000USD-76,935,000USD-53,353,000USD-33,127,000USD-25,669,000USD-15,045,000USD
    Total Cashflows From Investing Activities-224,000USD-385,000USD-791,000USD-970,000USD-813,000USD-953,000USD-672,000USD-570,000USD
    Net Borrowings0USD4,151,000USD0USD—0USD20,480,000USD14,000,000USD14,000,000USD
    Total Cash From Financing Activities1,791,000USD4,964,000USD1,104,000USD1,248,000USD252,529,000USD73,401,000USD42,664,000USD12,203,000USD
    Change In Cash-28,127,000USD-17,772,000USD-46,871,000USD-75,687,000USD199,176,000USD40,274,000USD16,995,000USD-2,842,000USD
    Begin Period Cash Flow120,357,000USD138,129,000USD185,000,000USD260,687,000USD61,511,000USD21,237,000USD4,242,000USD7,084,000USD
    End Period Cash Flow92,230,000USD120,357,000USD138,129,000USD185,000,000USD260,687,000USD61,511,000USD21,237,000USD4,242,000USD
    Other Cashflows From Financing Activities-58,000USD-261,000USD-224,000USD1,248,000USD-4,151,000USD52,921,000USD28,664,000USD12,203,000USD
    Unclassified Financing Cash Flow1,849,000USD1,074,000USD1,552,000USD——-53,400,000USD-30,750,000USD-26,226,000USD
    Investments—-385,000USD-656,000USD-970,000USD-813,000USD-953,000USD-672,000USD-570,000USD
    Sale Purchase Of Stock——-224,000USD576,000USD257,035,000USD———
    Change To Liabilities———3,657,000USD1,168,000USD448,000USD168,000USD1,003,000USD
    Issuance Of Capital Stock———0USD256,680,000USD53,400,000USD30,750,000USD12,226,000USD
    Cash And Cash Equivalents Changes———-75,687,000USD199,176,000USD———
    Unclassified Operating Cash Flow————7,760,000USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31SegmentDry Eye1,354,000USD0001193125-26-209116
    Q1 2026Quarterly · 2026-03-31SegmentSurgical Glaucoma18,344,000USD0001193125-26-209116
    Q4 2025Quarterly · 2025-12-31SegmentDry Eye724,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentSurgical Glaucoma19,661,000USDLegacy provider
    FY 2025Yearly · 2025-12-31SegmentDry Eye1,639,000USD0001193125-26-091558
    FY 2025Yearly · 2025-12-31SegmentSurgical Glaucoma75,724,000USD0001193125-26-091558
    Q3 2025Quarterly · 2025-09-30SegmentDry Eye188,000USD0001193125-25-269613
    Q3 2025Quarterly · 2025-09-30SegmentSurgical Glaucoma19,718,000USD0001193125-25-269613
    Q2 2025Quarterly · 2025-06-30SegmentDry Eye333,000USD0000950170-25-105065
    Q2 2025Quarterly · 2025-06-30SegmentSurgical Glaucoma19,231,000USD0000950170-25-105065
    Q1 2025Quarterly · 2025-03-31SegmentDry Eye394,000USD0001193125-26-209116
    Q1 2025Quarterly · 2025-03-31SegmentSurgical Glaucoma17,114,000USD0001193125-26-209116
    Q4 2024Quarterly · 2024-12-31SegmentDry Eye305,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentSurgical Glaucoma18,769,000USDLegacy provider
    FY 2024Yearly · 2024-12-31SegmentDry Eye3,964,000USD0001193125-26-091558
    FY 2024Yearly · 2024-12-31SegmentSurgical Glaucoma75,902,000USD0001193125-26-091558
    Q3 2024Quarterly · 2024-09-30SegmentDry Eye1,525,000USD0001193125-25-269613
    Q3 2024Quarterly · 2024-09-30SegmentSurgical Glaucoma18,632,000USD0001193125-25-269613
    Q2 2024Quarterly · 2024-06-30SegmentDry Eye1,126,000USD0000950170-25-105065
    Q2 2024Quarterly · 2024-06-30SegmentSurgical Glaucoma20,244,000USD0000950170-25-105065
    FY 2023Yearly · 2023-12-31SegmentDry Eye6,746,000USD0000950170-25-035500
    FY 2023Yearly · 2023-12-31SegmentSurgical Glaucoma74,310,000USD0000950170-25-035500
    FY 2022Yearly · 2022-12-31SegmentDry Eye5,737,000USD0000950170-24-030278
    FY 2022Yearly · 2022-12-31SegmentSurgical Glaucoma65,594,000USD0000950170-24-030278
    FY 2021Yearly · 2021-12-31SegmentDry Eye2,460,000USD0000950170-23-008526
    FY 2021Yearly · 2021-12-31SegmentSurgical Glaucoma46,496,000USD0000950170-23-008526
    FY 2020Yearly · 2020-12-31SegmentDry Eye1,640,000USD0000950170-22-004563
    FY 2020Yearly · 2020-12-31SegmentSurgical Glaucoma26,000,000USD0000950170-22-004563

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.